Dr. Aditya Singh Pawar, MD

Dr. Pawar practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.

Dr. Pawar's NPI, 1841631900, was assigned on July 17, 2013. Dr. Pawar holds Massachusetts license 286148.

Dr. Pawar's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.

Dr. Pawar's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. Dr. Pawar is also affiliated with Lahey Clinic. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Dr. Pawar to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pawar practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Pawar's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Pawar is licensed in Massachusetts.

CMS data shows 635 Medicare services from Dr. Pawar across 5 procedure codes in 2024, for 239 Medicare patients. Medicare paid $42,245 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 239 Medicare patients who saw Dr. Pawar in 2024. The largest group is under 65, with 120 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 49% are also on Medicaid. Their average risk score is 5.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pawar's median patient age at 63, with 38% women.

In 2024, Dr. Pawar wrote 1,255 Medicare Part D claims for 140 patients. 94% of them were for generic drugs. CMS names the drug for 1,092 of them, across 26 drugs with 11 or more claims each, at $145,275 in total drug cost. In 2023, CMS named 1,066 claims across 23 drugs.

Dr. Pawar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pawar as offering telehealth.

Dmand AI links 26 papers to Dr. Pawar, published from 2012 to 2024. 2024 was the busiest year, with 3. The most frequent topics are Swine, Kidney and Obesity. Dr. Pawar has published most often in Transplant Proc. Dr. Pawar's most frequent co-authors are Robert C. Albright, DO, Wisit Cheungpasitporn, MD and Stephen B. Erickson, MD.

CMS Open Payments shows 2 general payments to Dr. Pawar from 2 drug and device companies in 2016. Food and beverage make up the largest share, 100% of the total. Valeant Pharmaceuticals International paid the most, $103.